Anxiety is considered a natural response to stress. However, a state of heightened anxiety, called anxiety disorder, prevents thousands of people from living their best lives. While several underlying mechanisms have been therapeutically targeted, much remains to be discovered about this disorder. In an effort to get closer to unraveling the mechanisms that govern this condition, researchers have identified a drug that reduces glutamate-induced neurotransmission, involved in anxiety-like behavior.